Celescreen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 2


  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $35.7K

  • Investors
  • 1

Celescreen General Information


Developer of alternative toxicology testing methods designed to measure the toxicity of foreign chemical substances. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products, enabling physicians to evaluate systemic toxicity, nephrotoxicity, and teratogenicity, while avoiding vertebrate testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Corporate Office
  • 2 Rue Ambroise Paré
  • 75010 Paris
  • France
+33 06 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celescreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 20-Aug-2019 $35.7K 000.00 00000 Completed Product Development
2. Angel (individual) 13-Apr-2017 000.00 000.00 00000 Completed Product Development
1. Accelerator/Incubator 11-Sep-2014 Completed Product Development
To view Celescreen’s complete valuation and funding history, request access »

Celescreen Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 16,000 $1.114790 $2.68 $2.68 1x $2.68 29.09%
To view Celescreen’s complete cap table history, request access »

Celescreen Executive Team (4)

Name Title Board Seat Contact Info
Luc Lenglet Ph.D Chief Executive Officer
Jean-Marc Josse President
Phillipe Manivet Ph.D Founder & Scientific Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Celescreen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celescreen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Celescreen’s complete investors history, request access »

Celescreen FAQs

  • When was Celescreen founded?

    Celescreen was founded in 2014.

  • Who is the founder of Celescreen?

    Camille Hetez and Phillipe Manivet Ph.D are the founders of Celescreen.

  • Who is the CEO of Celescreen?

    Luc Lenglet Ph.D is the CEO of Celescreen.

  • Where is Celescreen headquartered?

    Celescreen is headquartered in Paris, France.

  • What is the size of Celescreen?

    Celescreen has 2 total employees.

  • What industry is Celescreen in?

    Celescreen’s primary industry is Decision/Risk Analysis.

  • Is Celescreen a private or public company?

    Celescreen is a Private company.

  • What is the current valuation of Celescreen?

    The current valuation of Celescreen is 00000.

  • What is Celescreen’s current revenue?

    The current revenue for Celescreen is 000000.

  • How much funding has Celescreen raised over time?

    Celescreen has raised $98.2K.

  • Who are Celescreen’s investors?

    Agoranov has invested in Celescreen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »